Oftalmoloxía
Servicio
Hospital Universitari de Bellvitge
l'Hospitalet de Llobregat, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitari de Bellvitge (22)
2024
-
Fight Retinal Blindness SPAIN. Report 3: clinical outcomes of vascular endothelial growth factor inhibitors in low vision eyes with neovascular age-related macular degeneration. A national database study
Eye (Basingstoke)
-
Macular Neovascularization Type Influence on Anti-VEGF Intravitreal Therapy Outcomes in Age-Related Macular Degeneration
Ophthalmology Retina, Vol. 8, Núm. 4, pp. 350-359
-
Protocolo de tratamiento del edema macular quístico asociado a retinosis pigmentaria y otras distrofias hereditarias de la retina
Archivos de la Sociedad Española de Oftalmologia, Vol. 99, Núm. 2, pp. 67-81
2023
-
Ausencia de vascularización periférica temporal como consecuencia de retinopatía de la prematuridad
Annals d'oftalmologia: òrgan de les Societats d'Oftalmologia de Catalunya, Valencia i Balears, Vol. 31, Núm. 3
-
Epiretinal neovascular membrane in Macular Telangiectasia type 2: Multimodal imaging diagnosis
European Journal of Ophthalmology
-
Perspectives of Therapeutic Drug Monitoring of Biological Agents in Non-Infectious Uveitis Treatment: A Review
Pharmaceutics, Vol. 15, Núm. 3
2022
-
Incidence, Risk Factors, and Outcomes of Rhegmatogenous Retinal Detachment after Intravitreal Injections of Anti-VEGF for Retinal Diseases: Data from the Fight Retinal Blindness! Registry
Ophthalmology Retina, Vol. 6, Núm. 11, pp. 1044-1053
2021
-
Economic burden of age-related macular degeneration in routine clinical practice: the RAMDEBURS study
International Ophthalmology, Vol. 41, Núm. 10, pp. 3427-3436
2020
-
Bimonthly, treat-and-extend and as-needed ranibizumab in naïve neovascular age-related macular degeneration patients: 12-month outcomes of a randomized study
Acta Ophthalmologica, Vol. 98, Núm. 7, pp. e820-e829
2018
-
Association between CFH, CFB, ARMS2, SERPINF1, VEGFR1 and VEGF polymorphisms and anatomical and functional response to ranibizumab treatment in neovascular age-related macular degeneration
Acta Ophthalmologica, Vol. 96, Núm. 2, pp. e201-e212
-
Clinical decision-making when treating diabetic macular edema patients with dexamethasone intravitreal implants
Ophthalmologica, Vol. 240, Núm. 2, pp. 61-72
-
Efficacy and safety of an aflibercept treat-and-extend regimen in treatment-naïve patients with macular oedema secondary to Central Retinal Vein Occlusion (CRVO): A Prospective 12-Month, Single-Arm, Multicentre Trial
Journal of Ophthalmology, Vol. 2018
2015
-
Individualized Therapy with Ranibizumab in Wet Age-Related Macular Degeneration
Journal of Ophthalmology, Vol. 2015
-
Treatment of Exudative Age-related Macular Degeneration: Focus on Aflibercept
Drugs and Aging, Vol. 32, Núm. 10, pp. 797-807
2014
-
A Delphi study to detect deficiencies and propose actions in real life treatment of neovascular age-related macular degeneration
Journal of Ophthalmology, Vol. 2014
-
Do nutritional supplements have a role in age macular degeneration prevention?
Journal of Ophthalmology, Vol. 2014
2012
2010
-
Photodynamic therapy for chronic central serous chorioretinopathy
Acta Ophthalmologica, Vol. 88, Núm. 3, pp. 371-376
-
Twelve-month outcome after one intravitreal injection of bevacizumab to treat myopic choroidal neovascularization
Retina, Vol. 30, Núm. 10, pp. 1609-1615
2009
-
A 1-year retrospective review of ranibizumab for naïve nonsubfoveal choroidal neovascularization secondary to age-related macular degeneration
Retina, Vol. 29, Núm. 10, pp. 1444-1449